Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Every investor in OncoCyte Corporation ( NASDAQ:OCX ) should be aware of the most powerful shareholder groups...
Social media campaign brings awareness to outstanding women surgeons and encourages equal representation in surgical oncology fieldIRVINE, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, announced today that it is proud to present the #ShesMySurgeon campaign in ho
RENO, Nev., Jun 15, 2021--Echelon Diagnostics and Oncocyte join forces to develop analytical software that can scale to support Oncocyte's clinical tests and solutions
Gruppo Oncologico del Nord Ovest, a Leading European Clinical Trials Group, Conducts Independent Investigator-Sponsored Clinical Trials for Pharmaceutical Targeted and Immune Therapies If Successful, Oncocyte’s DetermaIO Test for Immune Therapy Response Prediction Will Be Validated in a Fifth Tumor Type, Strengthening the Potential for Pan-Cancer Utility IRVINE, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a molecular diagnostics company with a mission to provide
Oncocyte’s Nashville CLIA lab now offers the Therascreen RGQ KRAS test Addition of the Therascreen RGQ KRAS test strengthens Oncocyte’s one-stop shop offering for lung cancer treatment decisions IRVINE, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NASDAQ: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, has signed an agreement with QIAGEN N.V. to support the launch of Amgen’s LUMAKR...
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...